Lv01
0 积分 2025-07-11 加入
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis
3小时前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
1个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
1个月前
已完结
Deoxyribonucleic Acid Topoisomerase Inhibitors
1个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
1个月前
已完结
P3.13D.11 SEZ6 Expression in Neuroendocrine Tumors
1个月前
已完结
皖公网安备34019202002308
